MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Opsoclonus myoclonus ataxia syndrome in a seronegative patient with disseminated cryptococcosis: The first case report

K. Sakdisornchai, J. Sringean, O. Jitkritsadakul, R. Bhidayasiri (Bangkok, Thailand)

Meeting: 2016 International Congress

Abstract Number: 932

Keywords: Ataxia: Etiology and Pathogenesis, Myoclonus: Etiology and Pathogenesis

Session Information

Date: Tuesday, June 21, 2016

Session Title: Myoclonus

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To describe a 56-year-old man who presented with OMA due to disseminated cryptococcosis.

Background: Opsoclonus-myoclonus-ataxia syndrome (OMA) is a rare neurological syndrome,characterized by a rapid onset of generalized myoclonus with multidirectional chaotic eye movements,and less frequently cerebellar ataxia.While the association of OMA and paraneoplastic syndrome is well described,OMA may occur as a result of various viral agents.

Methods: A 56-year old Thai male presented with a 1-month fever and diffuse headache.The positional-unrelated headache was mild persistent.He was admitted for inguinal hernia surgery but the examination showed generalized action myoclonus affecting his hands when outstretched and bouncing gait when he walked.He described intermittent oscillopsia ,truncal ataxia, and dysdiadochokinesia bilaterally.He walked with a wide-based and sway laterally.Routine laboratory investigations were normal.Lumbar tap indicated pressure of 18 cmH2O,with pleocytosis (WBC = 111 cells, Lym 73%), protein of 270mg/dL, and a low glucose level of 13 mg/dL.An CSF study was positive for cyptococcal antigen (CSF 1:2048, serum 1:512),and the culture was Cryptococcus neoformans.Serum Anti-Gamma interferon was positive (3.354; negative control 0.673, positive control 2.933).CSF study of viral antibodies were all negative.MRI brain revealed a leptomeningeal enhancement involving brainstem and cerebellum and a 5-mm ring-enhancing lesion suspected of cryptococcoma with surrounding edema in the left postcentral gyrus.An enhancing lung nodule consistent with cryptococcoma was identified on chest CT.

Results: We described a seronegative patient with disseminated cryptococcosis who presented with OMA.Despite no evidence of immunological deficiency, we suspected anti-interferon gamma might be indicated of altered immunological status due to an evidence from in-vivo study found increasing level of interferon gamma for cryptococcal infection clearance. An increasing of immune regulation might explain OMA syndrome.While infectious or parainfectious causes of OMA has been reported mainly with virus, we are not aware of any literature documenting the OMA with cryptococcal infection.

Pathogen Ref/number of patients Age/sex Diagnosis Ocular signs Myoclonus Cerebellar ataxia Lab investigations
Virus 1Wiest et al. 3 cases 45 F Respiratory tract infection (Enterovirus) Ocular flutter No Yes Antibody titres to Enterovirus
    33 F Respiratory tract infection Ocular flutter No Yes All negative including viral studies
    28 F Respiratory tract infection Ocular flutter No Yes All negative including viral studies
  2Alshekhlee et al. 1 case 53 M West nile virus encephalitis Opsoclonus Yes Yes IgM antibodies to west nile virus positive in CSF
  3Verma et al. 1 case 50 M EBV infection Opsoclonus Yes Yes PCR for EBV genome in csf and blood were positive
  4Kanjanasut et al. 2cases 25 M HIV infection Opsoclonus Yes Yes HIV antibody positive
    39 M HIV infection Opsoclonus Yes Yes HIV infection CD4: increased from 415 to 552cells/uL ,Viral load <50copies/ml
  5Zaganas et al. 1 case 30 M CMV encephalitis Opsoclonus Yes No Positive PCR and high IgG titers in CSF and rising serum IgM and IgG titers of CMV
  6Ai et al. 2 cases 30 M Dengue fever Opsoclonus Yes No Positive serum dengue IgM
    10 M Dengue shock syndrome Opsoclonus Yes Yes Positive dengue IgM and NS1 antigen
Bacteria 7Peter et al. 1 case 40 F Lyme disease Opsoclonus Yes Yes [uarr]B.burgdorferi IgM positive in CSF
  8Flabeau et al. 1 case 62 M Salmonellosis Ocular flutter Yes Yes Stool culture positive for salmonella enterica
  9Dassan et al. 1 case 31 F Streptococcal infection Opsoclonus Yes No ASOT = 400 U/mL
Post-vaccination 10Lapenna et al. 1 case 30 F Post-vaccinic (vaccine) Opsoclonus Yes No All negative
“

Conclusions: We reported the first case of OMA as a result of cryptococcosis in a seronegative patient.The development of OMA is likely to be related to altered immune status.

To cite this abstract in AMA style:

K. Sakdisornchai, J. Sringean, O. Jitkritsadakul, R. Bhidayasiri. Opsoclonus myoclonus ataxia syndrome in a seronegative patient with disseminated cryptococcosis: The first case report [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/opsoclonus-myoclonus-ataxia-syndrome-in-a-seronegative-patient-with-disseminated-cryptococcosis-the-first-case-report/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/opsoclonus-myoclonus-ataxia-syndrome-in-a-seronegative-patient-with-disseminated-cryptococcosis-the-first-case-report/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley